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Abstract 
Background: Failure of cerebral autoregulation and progression of intracranial lesion have both been shown to 
contribute to poor outcome in patients with acute traumatic brain injury (TBI), but the interplay between the two 
phenomena has not been investigated. Preliminary evidence leads us to hypothesize that brain tissue adjacent to 
primary injury foci may be more vulnerable to large fluctuations in blood flow in the absence of intact autoregulatory 
mechanisms. The goal of this study was therefore to assess the influence of cerebrovascular reactivity measures on 
radiological lesion expansion in a cohort of patients with acute TBI.
Methods: We conducted a retrospective cohort analysis on 50 TBI patients who had undergone high-frequency 
multimodal intracranial monitoring and for which at least two brain computed tomography (CT) scans had been 
performed in the acute phase of injury. We first performed univariate analyses on the full cohort to identify non-
neurophysiological factors (i.e., initial lesion volume, timing of scan, coagulopathy) associated with traumatic lesion 
growth in this population. In a subset analysis of 23 patients who had intracranial recording data covering the period 
between the initial and repeat CT scan, we then correlated changes in serial volumetric lesion measurements with 
cerebrovascular reactivity metrics derived from the pressure reactivity index (PRx), pulse amplitude index (PAx), and 
RAC (correlation coefficient between the pulse amplitude of intracranial pressure and cerebral perfusion pressure). 
Using multivariate methods, these results were subsequently adjusted for the non-neurophysiological confounders 
identified in the univariate analyses.
Results: We observed significant positive linear associations between the degree of cerebrovascular reactivity impair-
ment and progression of pericontusional edema. The strongest correlations were observed between edema progres-
sion and the following indices of cerebrovascular reactivity between sequential scans: % time PRx > 0.25 (r = 0.69, 
p = 0.002) and % time PAx > 0.25 (r = 0.64, p = 0.006). These associations remained significant after adjusting for initial 
lesion volume and mean cerebral perfusion pressure. In contrast, progression of the hemorrhagic core and extra-axial 
hemorrhage volume did not appear to be strongly influenced by autoregulatory status.
Conclusions: Our preliminary findings suggest a possible link between autoregulatory failure and traumatic edema 
progression, which warrants re-evaluation in larger-scale prospective studies.
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Introduction
Impairment of cerebrovascular autoregulatory mecha-
nisms has been shown to be associated with worse global 
outcome in neurologically injured patients, particularly 
in the acute traumatic brain injury (TBI) population [2, 
3]. The most commonly used continuous indices of global 
cerebral autoregulation are based on moving correlation 
coefficients between mean arterial (MAP) or cerebral 
perfusion pressure (CPP) and a surrogate of cerebral 
blood volume, typically inferred from continuous meas-
urements of intracranial pressure (ICP). The pressure 
reactivity index (PRx), for example, is derived from the 
correlation between ICP and MAP and has shown strong 
independent association with mortality and morbid-
ity at 6 months in a retrospective cohort of TBI patients 
[4]. Indices based on the pulse amplitude of ICP (AMP) 
which better reflect compliance such as PAx (the mov-
ing correlation between MAP and AMP) and RAC (the 
moving correlation between CPP and AMP) have also 
been linked to outcome and may be more discriminating 
than PRx at lower thresholds of ICP [5, 6]. However, the 
pathophysiological mechanisms through which impaired 
cerebrovascular reactivity contributes to poorer outcome 
remain unclear.
One candidate for translation of such abnormal patho-
physiology to structural injury may be lesion progression. 
Delayed lesion expansion can lead to worsened second-
ary injury and has also been associated with poorer out-
come [7–10]. Patients with radiological progression are 
also more likely to require surgical procedures, thereby 
putting them at risk of surgery-related complications and 
contributing to the length of stay and overall treatment 
and rehabilitation costs [9, 11].
Preliminary evidence from animal studies indicates that 
the energy transferred at the time of injury affects cer-
ebrovascular responses in both the hemorrhagic lesion 
core and perilesional zones and can impair microvascular 
function even in the absence of overt structural vascular 
damage [12, 13]. We hypothesized that impaired autoreg-
ulation could contribute to traumatic lesion expansion by 
decreasing the brain’s capacity to protect itself from fluc-
tuations in arterial pressures, thus subjecting vulnerable 
downstream microvessels to high stress. This issue has 
not, to our knowledge, been formally investigated in the 
past. However, documenting such a relationship could 
improve precision medicine approaches to TBI man-
agement, by identifying a risk factor for lesion expan-
sion, establishing a proximate structural consequence 
of physiological derangements, informing the frequency 
and timing of follow up imaging, and stratifying patients 
at high risk of needing surgical intervention and more 
aggressive medical therapies.
The goal of this study was therefore to explore the rela-
tionship between indices of cerebrovascular reactivity 
and traumatic lesion progression in a cohort of acute TBI 
patients. Given the wide range of autoregulatory indices 
available, and the range of summary measures that can 
be derived for each of these, we also wished to determine 
which of these showed the strongest associations with 
hemorrhagic or edema expansion, so as to provide the 
best candidates for a subsequent confirmatory study.
Methods
This was a retrospective analysis of a prospectively main-
tained database cohort, in which high-frequency clinical 
neuromonitoring data had been archived. Monitoring of 
brain modalities was conducted between October 2006 
and April 2014 as a part of standard neurosciences criti-
cal care unit (NCCU, Addenbrooke’s Hospital Cam-
bridge) patient care. Relevant clinical data were recorded 
at the time of monitoring, and no attempt was made 
to re-access clinical records for additional informa-
tion. Since all data were extracted from routine hospi-
tal records and fully anonymized before analysis, the 
need for formal review and consent not required. Such 
research use of routine clinical data, originally collected 
as part of ongoing clinical care, without the intention of 
using it for research at the time of collection, complies 
with UK Governance Arrangements for Research Eth-
ics Committees (GAfREC), 2018 [1], and this was recon-
firmed through electronic communication with the UK 
National Health Service Health Research Authority (doc-
ument on file).
Study Population
A total of 50 patients were included in this study. Inclu-
sion criteria were age > 18  years, a diagnosis of TBI 
requiring admission to the neurointensive care unit for 
sedation and ventilation, the presence of archived high-
frequency digital physiology from multimodality moni-
toring performed as part of clinical care, availability of an 
admission computed tomography (CT) scan and repeat 
scan performed during the acute period, defined within 
7  days of injury. Patients who underwent a decompres-
sive craniectomy were excluded unless two CT scans had 
been performed prior to surgical decompression. This 
decision was based on the difficulties in making reliable 
comparisons between serial lesion measurements in this 
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subgroup and the impact of craniectomy on measure-
ment of cerebrovascular reactivity indices [36]. Patients 
were managed according to the TBI treatment guidelines 
in effect during the study period, including ICP-directed 
therapy aimed at maintaining an ICP of less than 20 mm 
Hg and a CPP of greater than 60 mm Hg [14].
Data Collection
Baseline demographic (age, gender) and clinical data 
(Glasgow Coma Scale (GCS) score, pupillary reactiv-
ity) were recorded at the time of admission to our facil-
ity (admission GCS was scored pre-intubation). Data 
collected included the length of stay in the NCCU and 
6-month functional outcome when available (Glasgow 
Outcome Scale).
Intracranial Monitoring
Arterial blood pressure was measured through a radial 
or femoral line connected to a pressure transducer (Bax-
ter Healthcare Corp, CardioVascular Group, Irvine, CA, 
USA). When the clinical team determined that invasive 
intracranial neuromonitoring was indicated, an intra-
parenchymal ICP monitor (Codman ICP MicroSen-
sor, Codman & Shurtleff Inc., Raynham, MA, USA) was 
placed using triple bolt intracranial access kit [15]. Sig-
nals were digitized using an A/D converter (DT9800 
series, Data Translation, Marlboro, MA, USA) and sam-
pled using ICM + software (Cambridge Enterprise Ltd, 
Cambridge, UK, http://www.neuro surg.cam.ac.uk/icmpl 
us).
Processing of the acquired signals was performed 
using ICM + software as previously described [5, 6]. The 
focus was on the relationship between slow waves of ICP, 
arterial blood pressure and CPP (CPP = MAP–ICP), 
as such the parent high-frequency signals were down-
sampled to 0.1  Hz using a 10-s moving average filter. 
AMP was defined as the Fourier amplitude of the ICP 
pulse waveform over this window, updated every 10  s. 
PRx, PAx, and RAC were derived by calculating mov-
ing correlation coefficients between slow-wave fluctua-
tions ICP and MAP, AMP and MAP, or AMP and CPP, 
respectively, using 30 consecutive 10-s windows updated 
every minute. For all of these measures, more positive 
measurement values represent greater impairment in 
cerebrovascular reactivity (PRx, PAx) or combined cere-
brovascular reactivity and cerebrovascular compensatory 
reserve (RAC) [6, 16].
Imaging
Axial CT scans for each patient were downloaded in a 
Digital Imaging and Communication in Medicine for-
mat, assigned a study identifier that associated it with the 
anonymized physiological and clinical data available for 
the patient, and converted to anonymized Neuroimag-
ing Informatics Technology Initiative format for analysis. 
Traumatic intracranial lesions were digitally segmented 
by an expert clinician, a method which has shown supe-
rior accuracy to the commonly used pragmatic volume 
measurements such as ellipsoid or Cavalieri approxi-
mation [17]. A bespoke image segmentation tool devel-
oped in the BioMedIA group at Imperial College London 
with a set of labels customized for traumatic brain lesion 
annotations was used (ImSeg, v1.9, Imperial College 
London, UK). This technique has demonstrated adequate 
inter- and intra-observer reliability for our imaging data-
set, with inter-rater intraclass correlation coefficients 
(ICCs) of 0.97 (95% CI 0.92–0.99), 0.97 (95% CI 0.90–
0.99), and .98(95% CI .94–.99) for contusion core, edema 
and extra-axial hemorrhage, respectively, and intra-rater 
ICCs of 0.98 (95% CI 0.92–0.99), 0.97 (95% CI 0.90–0.99), 
and 0.98(95% CI 0.94–0.99), respectively. These reliabil-
ity coefficients are in line with those reported in a larger 
study of intracerebral hemorrhage measurements on CT 
[18]. Extra-axial lesions were divided into epidural, sub-
dural, and subarachnoid hemorrhage. Intra-parenchy-
mal lesions were parcellated based on type (core versus 
edema, nontraumatic). A representative set of segmenta-
tions is shown in Fig. 1. Segmentations were validated by 
a second clinician with specialist expertise in neuroradi-
ology. The clinicians assessing the lesions were blinded to 
the patient’s cerebrovascular reactivity status. Segmented 
lesion volumes were extracted using FSL v6.0 (NeuroIm-
age, https ://fsl.fmrib .ox.ac.uk/fsl/fslwi ki/FSL) for subse-
quent analyses.
Outcome Measures
The exposure of interest was autoregulatory status in the 
acute phase of TBI, and the primary outcome was radio-
logical lesion progression during this same period. Lesion 
progression was calculated by subtracting absolute lesion 
volumes (measured in mL) on the initial scan from the 
repeat scan. Total averages [19] and percent of monitor-
ing time spent above thresholds were calculated for each 
cerebrovascular reactivity index for the interval between 
the initial and repeat scan. The critical thresholds of 
0.25 for PRx and PAx and − 0.10 for RAC were chosen 
based on the previous literature suggesting that these 
cutoffs predict poor 6-month functional outcome in non-
craniectomized TBI patients [20].
Statistical Analysis
Data were analyzed using R (R Core Team (2016); R: a 
language and environment for statistical computing; R 
Foundation for Statistical Computing, Vienna, Austria; 
URL https ://www.R-proje ct.org/) and JMP Pro software 
(version 14, SAS Institute Inc., Cary, NC, 1989–2019). 
For all reported p values, the alpha was set as 0.05 for 
significance.
The descriptive statistics used to assess the charac-
teristics of our cohort are reported as mean (standard 
deviation) for normally distributed continuous variable 
and median (range or interquartile range) for ordinal 
data, and categorical variables are represented as propor-
tions of the total sample. Generalized linear regression 
was used to look at associations between non-neuro-
physiological factors including initial lesion size, inter-
val between the initial and repeat scan, the presence of 
a documented coagulopathy during this interval (defined 
as a PT > 13.5  s, aPTT > 35  s or platelets < 100/nL), and 
traumatic lesion growth. We also included mean CPP 
as another potential confounding factor, based on the 
concern that a relatively higher CPP target in patients 
with more severe intracranial injuries could contrib-
ute to hemorrhage or edema expansion [21, 22]. Scatter 
plot matrices, Pearson correlation analyses, and linear 
mixed-model regression were then used to look for lin-
ear relationships between cerebrovascular reactivity 
metrics and lesion change in the subset of patients with 
intracranial recordings covering the between-scan inter-
val. Correlation and regression coefficients were calcu-
lated for each lesion label as well as collapsed categories 
(total contusion core, total contusion-related edema, and 
total extra-axial hemorrhage volume). Using multivari-
ate generalized linear mixed regression methods, these 
coefficients were adjusted for non-neurophysiological 
parameters associated with lesion growth and CPP 
based on variables with a p value < 0.2 from the univari-
ate analysis, as well as baseline covariate including age, 
gender, and GCS on admission. Significant p values were 
tested against thresholds corrected for multiple compari-
sons using the Holm–Bonferroni method for both the 
adjusted and unadjusted models.
Results
Patient Characteristics
The patient demographics and clinical characteris-
tics for the entire cohort (n = 50) are summarized in 
Table  1. Admission (initial) CT scans were obtained 
within 7.3 ± 10.4  h of injury. Initial imaging findings 
and mean neurophysiological values over the record-
ing period are presented in Table 2. Given that the avail-
able repeat imaging studies were obtained within a mean 
of 62.4 ± 64.8  h of injury and that there were delays 
to initiation of monitoring for many patients (mean 
delay = 45.6 ± 31.2 h), only 23 of those patients had phys-
iological recordings data available for the period between 
the initial and repeat scans.
Association Between Non‑neurophysiological Factors 
and Absolute Lesion Change
Univariate regression analyses performed on the full 
cohort (n = 50) showed positive linear relationships 
between initial lesion volume, mean CPP, and progres-
sion of pericontusional edema (Table  3). There were no 
significant relationships between initial lesion volume, 
number of hours elapsed between initial and repeat 
scan, mean CPP, and the presence of a coagulopathy in 
Fig. 1 Representative set of segmented traumatic lesions on CT. Left: 
initial image; Right: segmented lesion(s). a Contusion core (blue) and 
peri-contusional edema (magenta), b epidural hematoma (green), 
c subdural hematoma (dark blue), d subarachnoid hemorrhage 
(red) and trace parafalcine extra-axial blood (dark blue). Right frontal 
hyperdensity in a and d represents the tip of the intracranial probe
the between-scan interval and growth of hemorrhagic 
core or extra-axial hemorrhage volume. P values for the 
associations between initial lesion volume, mean CPP, 
time elapsed between scans, and growth of lesion core 
were < 0.20 and therefore entered in the multivariate 
models.
Association Between Cerebrovascular Reactivity 
Measurements and Absolute Lesion Volume Change
Pearson correlational analyses showed significant posi-
tive linear associations between the degree of cer-
ebrovascular reactivity impairment and progression of 
pericontusional edema. Scatter plots with correspond-
ing correlation coefficients for relevant pairs of variables 
are displayed in Fig.  2. The strongest associations were 
observed between edema progression and percent time 
spent above a threshold of PRx > 0.25 (r = 0.69, p = 0.002) 
or PAx > 0.25 (r = 0.64, p = 0.006). In contrast, we found 
no significant correlations between any of the cerebro-
vascular reactivity metrics and progression of contusion 
core or extra-axial hemorrhage. We noted that an outlier 
appeared to be influencing correlations in both directions 
depending on the variable pair (Fig.  2). In a sensitivity 
analysis, a test exclusion of this data point did not change 
the overall significance levels for the majority of associa-
tions presented. The associations between the degree of 
cerebrovascular reactivity impairment and edema expan-
sion held true after adjustment for baseline covariates, 
potential non-neurophysiological factors, and mean 
CPP (Tables 4, 5) and after correcting for multiple com-
parisons. We decided to exclude extra-axial hemorrhage 
from the multivariate models given the lack of associa-
tions seen in the univariate analyses.  
Discussion
We sought to explore the relationship between cerebro-
vascular reactivity and traumatic intracranial lesion pro-
gression in a cohort of patients with acute traumatic 
brain injury and identify metrics of cerebrovascular reac-
tivity that showed the strongest associations with lesion 
progression. Overall, our results suggest a link between 
autoregulatory dysfunction and expansion of perilesional 
edema in the acute phase, replicated across two metrics 
of autoregulatory dysfunction.
Prior studies have identified a number of factors 
contributing to contusion expansion in the traumatic 
Table 1 Patient demographics and  baseline clinical char-
acteristics
GCS Glasgow Coma Scale, GOS Glasgow Outcome Scale, SD standard deviation
Characteristics Mean/
median (SD 
or range)
Number of patients 50
Age, years 35.6 (15.6)
Female, n (%) 15 (30)
Admission GCS total 6 (1–15)
Admission GCS motor 3 (1–6)
Pupils, n (%)
 Unilateral sluggish 2 (4)
 Bilateral sluggish 3 (6)
 Unilateral unreactive 4 (8)
 Bilateral unreactive 6 (12)
Length of stay in ICU, mean days 23 (8.8)
GOS at 6 months, n (%)
 1 4 (8)
 2 19 (38)
 3 16 (32)
 4 7 (14)
 Unavailable 4 (8)
Table 2 Initial imaging findings and  neurophysiological 
characteristics
n = number of patients with the type of lesion on initial CT (% of total sample); 
a.u. arbitrary units, ASDH acute subdural hematoma, CPP cerebral perfusion 
pressure, EDH epidural hematoma, ICP intracranial pressure, IVH intraventricular 
hemorrhage, PAx pulse amplitude index (correlation between pulse amplitude 
of intracranial pressure and mean arterial pressure), PRx pressure reactivity 
index (correlation between intracranial pressure and mean arterial pressure), 
RAC correlation between pulse amplitude of intracranial pressure and cerebral 
perfusion pressure, SAH subarachnoid hemorrhage, SD standard deviation
Mean/
median (SD 
or range)
Initial CT scan
 Marshall score 2 (1–6)
 Rotterdam score 3 (1–6)
 ASDH, n (%) 24 (48)
 EDH, n (%) 7 (14)
 SAH, n (%) 26 (52)
 IVH, n (%) 15 (30)
 Contusion, n (%) 41 (82)
  Superficial 39 (78)
  Deep 16 (32)
 Contusion volume, n (%)
 < 10 mL 36 (72)
 10–25 mL 2 (4)
 > 25 mL 3 (6)
Timing of initial scan, mean hours from injury 7.3 (10.4)
Timing of repeat scan, mean hours from injury 62.4 (64.8)
Length of physiological recordings, mean days 7.4 (5.4)
Mean ICP, mmHg 15.3 (9.7)
Mean CPP, mmHg 80.3 (7.9)
Mean PRx, a.u. 0.03 (0.14)
Mean PAx, a.u. −0.09 (0.16)
Mean RAC, a.u. −0.39 (0.22)
Table 3 Univariate associations for factors previously associated with lesion growth (n = 50)
Δ Core, absolute difference in volume (mL) for contusion core between initial and repeat scan; Δ Edema, absolute difference in volume (mL) for pericontusional 
edema between initial and repeat scan; Δ Extra-axial, absolute difference in total volume (mL) of extra-axial hemorrhage between initial and repeat scan, CPP cerebral 
perfusion pressure
Δ Core Δ Edema Δ Extra‑axial
Coefficient (95% CI) R2 p value Coefficient (95% CI) R2 p value Coefficient (95% CI) R2 p value
Initial lesion volume (mL) 0.16 [− 0.02 to 0.34] 0.08 0.07 0.64 [0.38 to 0.90] 0.42 < 0.0001 0.03 [− 0.13 to 0.21] 0 0.76
Interval between scans − 0.01 [− 0.03 to 0.01] 0.04 0.19 − 0.001 [− 0.04 to 0.04] 0 0.69 − 0.01 [− 0.03 to 0.01] 0.06 0.20
Mean CPP 0.14 [− 0.04 to 0.32] 0.06 0.14 0.37 [0.01 to 0.73] 0.1 0.05 − 0.01 [− 0.19 to 0.17] 0 0.89
Coagulopathy 0.60 [− 1.0 to 2.19] 0.02 0.44 0.28 [− 2.95 to 3.51] 0 0.86 0.26 [− 1.08 to 1.60] 0.04 0.70
Fig. 2 Scatter plot matrix of correlations between cerebrovascular reactivity status and radiological lesion progression. Recording interval between 
initial and repeat scan (n = 23). Correlation coefficients are shown in the top middle portion of each scatter plot. Δ Core, absolute difference in 
volume (mL) for contusion core between initial and repeat scan; Δ Edema, absolute difference in volume (mL) for peri-contusional edema between 
initial and repeat scan; Δ Extra-axial, absolute difference in total volume (mL) of extra-axial hemorrhage between initial and repeat scan, PAx pulse 
amplitude index (correlation between pulse amplitude of intracranial pressure and mean arterial pressure), PRx pressure reactivity index (correlation 
between intracranial pressure and mean arterial pressure, RAC correlation between pulse amplitude of intracranial pressure and cerebral perfusion 
pressure
setting, including age, initial contusion size, degree 
of overall mass effect, presence of coagulopathies, 
decompressive craniectomy, and timing of radiological 
assessment [7, 8, 10, 11, 23–33]. Few human studies, 
however, have attempted to isolate factors contribut-
ing to perilesional edema expansion separately from 
the hemorrhagic core. Preliminary evidence from ani-
mal data suggests that the kinetic energy transferred 
during the initial impact induces a molecular cascade 
which can trigger progressive microvascular failure 
in brain tissue adjacent to the primary injury site in 
the absence of overt vessel fracture [12, 13]. If this is 
the case, it is possible that loss of autoregulation may 
contribute to edema formation by allowing the trans-
mission of elevated pressures to the grossly structur-
ally intact, but functionally disrupted downstream 
microvasculature. A plausible alternative hypothesis 
would be that a larger edema volume is associated with 
greater impairment in cerebrovascular reactivity since 
it tends to reflect a more severe injury mechanism. 
However, this hypothesis is not supported by data 
showing a lack of significant association between total 
intracranial injury burden on admission CT scan and 
subsequent dysfunction in cerebrovascular reactivity 
[34]. While we cannot ascertain a direction of causality 
given the retrospective and highly exploratory nature 
of this study, this alternative hypothesis is also not sup-
ported by the lack of relationship between RAC-based 
measures and lesion expansion in our study. RAC is 
believed to incorporate additional information per-
taining to cerebral compensatory reserve—the degree 
to which incremental changes in intracranial con-
tents such as hemorrhagic or edematous lesions affect 
intracranial pressure—since it is derived from measur-
ing changes in pulse amplitude of ICP in response to 
fluctuations in cerebral perfusion pressure [6, 35]. If 
dysfunction of cerebrovascular reactivity was primar-
ily a by-product of increased mass effect from edema 
progression rather than a contributing cause, we would 
therefore expect this to be reflected by significant 
changes in the RAC index. In our study, the strong-
est associations with absolute lesion volume increase 
were in fact seen with PRx-based metrics, which has 
been the most widely studied thus far [36]. As the mov-
ing correlation between ICP and MAP, PRx is believed 
to primarily reflect the degree of intracerebral vessel 
reactivity [16]. Consequently, our results suggest that 
reactivity-dependent mechanisms may be involved in 
early traumatic edema development. However, we need 
to emphasize that our results are preliminary and that 
much more work will, however, be required to eluci-
date the temporal relationships between radiological 
Table 4 Linear associations between cerebrovascular reactivity impairment and contusion core progression (n = 23)
Δ Core, absolute difference in volume (mL) for contusion core between initial and repeat scan; %, percent time spent above respective thresholds; PAx pulse amplitude 
index (correlation between pulse amplitude of intracranial pressure and mean arterial pressure); PRx pressure reactivity index (correlation between intracranial 
pressure and mean arterial pressure);%, percent time spent above respective thresholds; Hrly hourly dose above respective thresholds, RAC correlation between pulse 
amplitude of intracranial pressure and cerebral perfusion pressure
Δ Core (unadjusted) Δ Core (adjusted)
Coefficient (95% CI) R2 p value Coefficient (95% CI) R2 (R2‑adj) p value
% Time spent PRx > 0.25 0.02 [− 0.02 to 0.07] 0.05 0.37 − 0.05 [− 0.17 to 0.05 ] 0.43 (0.13) 0.29
% Time spent PAx > 0.25 0.04 [− 0.02 to 0.11] 0.08 0.25 − 0.05 [− 0.24 to 0.13) 0.39 (0.06) 0.53
% Time spent RAC > − 0.10 0.01 [− 0.04 to 0.14] 0.01 0.71 − 0.03 [− 0.10 to 0.05] 0.41 (0.09) 0.41
Table 5 Linear associations between  cerebrovascular reactivity impairment and  pericontusional edema progression 
(n = 23)
Δ Edema, absolute difference in volume (mL) for pericontusional edema between initial and repeat scan; %, percent time spent above respective thresholds, PAx 
pulse amplitude index (correlation between pulse amplitude of intracranial pressure and mean arterial pressure), PRx pressure reactivity index (correlation between 
intracranial pressure and mean arterial pressure);%, percent time spent above respective thresholds; Hrly, hourly dose above respective thresholds; RAC correlation 
between pulse amplitude of intracranial pressure and cerebral perfusion pressure. Unadjusted model: exact p values for % time spent with PRx or PAx > 0.25 were 
0.0023 and 0.0058, respectively, tested against corrected thresholds of 0.05/9 = 0.0055 and 0.05/8 = 0.0063; Adjusted model: exact p values for % time spent with PRx 
or PAx > 0.25 were 0.0056 and 0.0042, respectively, testing against corrected threshold of 0.05/8 = 0.0063 and 0.05/9 = 0.0055.)
Δ Edema (unadjusted) Δ Edema (adjusted)
Coefficient (95% CI) R2 p value Coefficient (95% CI) R2 (R2‑adj) p value
% Time spent PRx > 0.25 0.30 [0.14 to 0.45 ] 0.47 < 0.01 0.36 [0.11 to 0.60] 0.58 (0.39) < 0.01
% Time spent PAx > 0.25 0.34 [0.14 to 0.54] 0.41 < 0.01 0.62 [0.24 to 1.00] 0.63 (0.45) < 0.01
% Time spent RAC > − 0.10 0.10 [− 0.09 to 0.18] 0.06 0.33 0.05 [− 0.19 to 0.30] 0.62 (0.40) 0.64
lesion evolution and changes in the various surrogate 
measures of cerebrovascular function employed in this 
study.
It is unclear why extra-axial hemorrhage growth 
appeared to poorly correlate with autoregulatory status, 
but a number of potential contributing factors deserve 
mention. First, it is important to keep in mind that most 
of the larger extra-axial lesions or those deemed at risk 
of progression would have been surgically evacuated 
shortly after presentation. Such lesions would there-
fore have been excluded from our study, introducing a 
selection bias into the extra-axial analyses. Second, the 
source vascular supply for extra-axial bleeding—typically 
meningeal feeders supplied by branches of the extracra-
nial circulation, dural venous sinuses or bone for epidural 
hematoma, and bridging veins for subdural hematoma—
should in theory not be directly susceptible to cerebral 
autoregulatory dysfunction, although a subset of sub-
dural hematomas is known to arise from extension of 
parenchymal contusion or cortical laceration across the 
pia-arachnoid membranes [37]. Third, conservatively 
managed extra-axial hemorrhages have been shown to 
redistribute over time, especially in older individuals with 
more pronounced brain atrophy, which may reduce the 
accuracy of serial volume measurements for this lesion 
subtype [38].
Limitations
The results of this study should be interpreted bearing in 
mind a number of important limitations. First, the small 
sample size limited our ability to detect significant asso-
ciations, especially when looking at less common lesion 
subtypes, and makes our analyses more vulnerable to 
outliers. Although we had originally planned to assess 
the influence of lesion location and subtype, this was 
not possible given the reduced sample size. Second, the 
retrospective nature of this study and the heterogeneity 
of our sample in terms of timing of radiological assess-
ment and onset of monitoring make our analyses vulner-
able to a range of selection and temporally dependent 
biases. Although a number of studies have shown that 
traumatic lesion expansion generally happens within the 
first 2 days of injury (mean repeat scan was obtained at 
2.6 days in our study) [11, 31], patients with more severe 
injury may have been more likely to get an early repeat 
imaging study, confounding the assessment of a dynamic 
relationship with the intracranial recording data. Third, a 
minority of patients had femoral rather than radial lines 
and assessment of mean arterial pressures may therefore 
not be perfectly comparable among all subjects. Fourth, 
we cannot account for the influence of ICP-lowering 
therapies and vasoactive agents, which are commonly 
used in this patient population, as such interventions 
were not measured as part of this study and evidence 
regarding their impact on cerebrovascular responses is 
lacking. For instance, the clinical team may have targeted 
a higher CPP for more injured patients with positive indi-
ces, which could contribute to lesion progression. We 
should also point out that the continuous indices of cere-
brovascular reactivity used in this study (PRx, PAx, RAC) 
reflect a global average of autoregulatory status and may 
not necessarily capture more focal physiological derange-
ments that could influence lesion expansion.
Conclusion
Despite these limitations, our findings point to a possi-
ble association between global autoregulatory failure and 
traumatic edema progression, which warrants re-evalu-
ation in larger-scale prospective studies. Future studies 
should also incorporate functional outcome measures to 
determine how these lesion–autoregulation relationships 
influence patient recovery at various timepoints after the 
acute phase.
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